[ET Net News Agency, 12 July 2024] HANSOH PHARMA (03692) rose 3.1% to HK$16.52,
breaking above the 20-D SMA of HK$16.465.
It hits an intra-day high of HK$16.54, and an intra-day low of HK$15.8. The total shares
traded was 786,942, with a value of HK$12.88m. The active buy/sell ratio is 80:20, with
net buying turnover of HK$7.56m. GOLDMAN SACHS (ASIA) SEC accounts for greatest net
responsive buying turnover of HK$491,513, with volume weighted average price of HK$16.323.
CLSA LTD accounts for greatest net responsive selling turnover of HK$2.46m, with volume
weighted average price of HK$16.382. The stock has risen a combined 3.5% over the past 2
consecutive trading days.
The Hang Seng Index now rose 363 points, or 2% to 18,195.

Basic Information
=================

----------------------------------
Nominal 16.520 % Chg +3.12%
High 16.540 Low 15.800
Shares Tr 786,942 Turnover 12.88m
10-D SMA 16.100 %H.V 36.031
20-D SMA 16.465 VWAP 16.367
50-D SMA 16.997 RSI14 50.460
----------------------------------
Status: Breaking above the 20-D SMA, active buy/sell ratio is 80:20, with net buying
turnover of HK$7.56m, rising a combined 3.5% over the past 2 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
HANSOH PHARMA (03692) 16.52 +3.12
ALI HEALTH (00241) 3.30 +3.77
TRAD CHI MED (00570) 3.53 +0.86
CSPC PHARMA (01093) 6.24 +1.96
SINOPHARM (01099) 19.88 +0.40
SINO BIOPHARM (01177) 2.88 +1.77
WUXI APPTEC (02359) 29.65 +2.24
CHINARES PHARMA (03320) 5.43 -0.37
JD HEALTH (06618) 22.60 +5.61
GOLDEN THROAT (06896) 3.15 Unchanged
-----------------------------------------------
(ed)